SCHEMBL2312142

SCHEMBL2312142

OCCc1cccc2cc3cc4ccccc4c(CCO)c3cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MTNR1A P48039 2/20 0.36
NQO2 P16083 1/20 0.36
GPR84 Q9NQS5 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
CYP1A2 P05177 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MCL1 Q07820 2/20 0.34
AKR1B1 P15121 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HNF4A P41235 1/20 0.34
DHODH Q02127 1/20 0.34
ACP3 P15309 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310413 0.87 L3MBTL1 (0.40) HTR2AL3MBTL1MTNR1AALDH1A1TSHR
SCHEMBL2307685 0.86 GPR84 (0.39) HTR2AL3MBTL1MTNR1ANQO2GPR84
SCHEMBL2312110 0.86 MTNR1A (0.39) HTR2AMTNR1ANQO2
SCHEMBL2313164 0.84 HTR2A (0.48) HTR2AL3MBTL1NQO2ALDH1A1TSHR
SCHEMBL240651 0.84 HTR2A (0.56) HTR2AL3MBTL1NQO2ALDH1A1TSHR
SCHEMBL2308132 0.83 CYP1A2 (0.51) HTR2AMTNR1ANQO2ALDH1A1TSHR
SCHEMBL1456304 0.83 ALDH1A1 (0.43) HTR2AMTNR1ANQO2ALDH1A1HSD17B10
SCHEMBL2313034 0.82 L3MBTL1 (0.43) HTR2AL3MBTL1MTNR1AALDH1A1TSHR
SCHEMBL2306866 0.81 KDM4E (0.42) HTR2AMTNR1ANQO2ALDH1A1TDP1
SCHEMBL2312427 0.80 MTNR1A (0.40) HTR2AMTNR1ANQO2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed